LENZ Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
LENZ Therapeutics Operating Expenses Growth & History (LENZ)
LENZ Therapeutics's operating expenses was $110.2M for fiscal 2025.
View full LENZ Therapeutics company overviewLENZ Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $110.2M | $51.6M | +88.07% |
| 2024 | 2024-12-31 | $58.6M | −$13.8M | −19.08% |
| 2023 | 2023-12-31 | $72.4M | −$33.2M | −31.44% |
| 2022 | 2022-12-31 | $105.6M | $45.2M | +74.77% |
| 2021 | 2021-12-31 | $60.4M | $46.9M | +347.73% |
| 2020 | 2020-12-31 | $13.5M | — | — |
LENZ Therapeutics quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $39.7M | $17.8M | +81.44% |
| Q1 2026 | 2026-03-31 | $46.0M | $29.1M | +171.90% |
| Q4 2025 | 2025-12-31 | $40.1M | $24.8M | +163.06% |
| Q3 2025 | 2025-09-30 | $31.4M | $18.4M | +142.46% |
| Q2 2025 | 2025-06-30 | $21.9M | $7.5M | +52.29% |
| Q1 2025 | 2025-03-31 | $16.9M | $843,000 | +5.24% |
| Q4 2024 | 2024-12-31 | $15.2M | −$9.8M | −39.07% |
| Q3 2024 | 2024-09-30 | $12.9M | −$6.9M | −34.84% |
| Q2 2024 | 2024-06-30 | $14.4M | −$607,000 | −4.06% |
| Q1 2024 | 2024-03-31 | $16.1M | $3.5M | +27.52% |
| Q4 2023 | 2023-12-31 | $25.0M | −$1.8M | −6.59% |
| Q3 2023 | 2023-09-30 | $19.9M | −$6.3M | −24.05% |
| Q2 2023 | 2023-06-30 | $15.0M | −$11.8M | −44.13% |
| Q1 2023 | 2023-03-31 | $12.6M | −$13.3M | −51.40% |
| Q4 2022 | 2022-12-31 | $26.8M | $7.8M | +41.24% |
| Q3 2022 | 2022-09-30 | $26.2M | $11.6M | +79.11% |
| Q2 2022 | 2022-06-30 | $26.8M | $9.2M | +52.72% |
| Q1 2022 | 2022-03-31 | $26.0M | $16.6M | +177.09% |
| Q4 2021 | 2021-12-31 | $18.9M | — | — |
| Q3 2021 | 2021-09-30 | $14.6M | $10.8M | +287.94% |
| Q2 2021 | 2021-06-30 | $17.5M | $16.2M | +1257.04% |
| Q1 2021 | 2021-03-31 | $9.4M | — | — |
| Q3 2020 | 2020-09-30 | $3.8M | — | — |
| Q2 2020 | 2020-06-30 | $1.3M | — | — |
LENZ Therapeutics operating expenses trends
Over the last five fiscal years, LENZ Therapeutics's operating expenses increased from $13.5M to $110.2M, a change of $96.7M. The latest reported quarter, Q2 2026, shows $39.7M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LENZ Therapeutics source filings ↗